ACT supports the production and distribution of a microbial restoration product that is saving lives and driving breakthrough research.

Treatment

Our mission is to save lives through microbial restoration. Through our partnership with the University of Minnesota Microbiota Therapeutics Program, we developed the first stool donor program and are the only academic program in the world that is manufacturing therapeutic microbiota in accordance with Good Manufacturing Practice protocols, a requirement for all pharmaceutical products. To date, we have produced over 13,000 capsules used to treat C. difficile patients and to target illnesses in clinical trials across the country.

Clostridium difficile is an antibiotic resistant infection that infects roughly 500,000 patients each year. ACT’s partnership with the University of Minnesota treats C. difficile patients locally and provides therapeutics to providers around the United States. Our therapeutics have treated over 1,000 patients with a 98% success curative rate against recurrent C. difficile infections.

Growth

Terri's Story

After suffering from recurrent Diverticulitis attacks for seven years, I became very sick with recurrent C. difficile Infections. For a season, I could only eat rice, eggs and potato chips. Finally, I found Dr. Khoruts at the University of Minnesota and ultimately received a Fecal Microbiota Transplant. I now have no pain, no diverticulitis attacks, and can eat pretty much anything I want. Thank you!
Read more
Growth

John's Story: A Donor's Perspective

John is a stool donor for the University of Minnesota Microbiota Therapeutics Program. He is an inspiration to us all and has selflessly helped countless people with his generous contributions.
Read more
Growth

Heidi's Story: A Family Member's Perspective

Heidi's sister suffered from C. difficile and received an FMT. In this video, Heidi shares her unique perspective as sje helplessly watching her loved one suffer. So many of us can relate and this is a beautiful testimony that will give you strength!
Read more
View All Stories

Sign up for our Newsletter

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form